Abstract
Abstract
Background
Insulin resistance (IR) increases vascular risk in individuals with Type 1 Diabetes (T1D). We aimed to investigate the relationship between dietary intake and IR, as well as vascular biomarkers in T1D.
Methods
Baseline data from three randomised controlled trials were pooled. Estimated glucose disposal rate (eGDR) was used as an IR marker. Employing multivariate nutrient density substitution models, we examined the association between macronutrient composition and IR/vascular biomarkers (tumour necrosis factor-α, fibrinogen, tissue factor activity, and plasminogen activator inhibitor-1).
Results
Of the 107 patients, 50.5% were male with mean age of 29 ± 6 years. Those with lower eGDR were older with a longer diabetes duration, higher insulin requirements, and an adverse vascular profile (p < 0.05). Patients with higher degrees of IR had higher total energy intake (3192 ± 566 vs. 2772 ± 268 vs. 2626 ± 395 kcal/d for eGDR < 5.1 vs. 5.1–8.6 vs. ≥ 8.7 mg/kg/min, p < 0.001) and consumed a higher absolute and proportional amount of fat (47.6 ± 18.6 vs. 30.4 ± 8.1 vs. 25.8 ± 10.4%, p < 0.001). After adjusting for total energy intake, age, sex, and diabetes duration, increased carbohydrate intake offset by an isoenergetic decrease in fat was associated with higher eGDR (β = 0.103, 95% CI 0.044–0.163). In contrast, increased dietary fat at the expense of dietary protein intake was associated with lower eGDR (β = − 0.119, 95% CI − 0.199 to − 0.040). Replacing fat with 5% isoenergetic amount of carbohydrate resulted in decreased vascular biomarkers (p < 0.05).
Conclusion
Higher fat, but not carbohydrate, intake is associated with increased IR and an adverse vascular profile in patients with T1D.
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference34 articles.
1. Helliwell R, Warnes H, Kietsiriroje N, Campbell M, Birch R, Pearson SM et al (2021) Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: beyond glycated haemoglobin. Diabetic Med 38:e14529. https://doi.org/10.1111/dme.14529
2. National Diabetes Audit, 2019–2020, Type 1 Diabetes 2021 [Available from: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/national-diabetes-audit-2019-20-type-1-diabetes. Accessed 03 Dec 2021
3. Merger SR, Kerner W, Stadler M, Zeyfang A, Jehle P, Muller-Korbsch M et al (2016) Prevalence and comorbidities of double diabetes. Diabetes Res Clin Pract 119:48–56. https://doi.org/10.1016/j.diabres.2016.06.003
4. Kietsiriroje N, Pearson S, Campbell M, Ariens RAS, Ajjan RA (2019) Double diabetes: a distinct high-risk group? Diabetes Obes Metab 21:2609–2618. https://doi.org/10.1111/dom.13848
5. Alzahrani SH, Ajjan RA (2010) Coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res 7:260–273. https://doi.org/10.1177/1479164110383723
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献